Although the effects of CD44 inhibition in cancer therapy remain controversial, numerous reports have shown effective reduction of malignancies, including colon, mammary, and ovarian cancers, following treatment with CD44 inhibitors [40]. The gene discussed is CD44; the disease is ovarian cancer.